The American journal Medicine, specialising in research articles on medical scientific disciplines and subspecialties, has recently published the clinical case of Repigment12. 

Bella Aurora continues with its international expansion plan with the opening of its new subsidiary in Brazil, the third of the company in the American continent. 

The Institute for Ethics in Communication and Organizations (IECO) of the University of Valencia has published the Decalogue of Good Practices in Humanistic Leadership and is the result of the work between academics and company executives, among which is Bella Aurora Labs. 

Recently, Bella Aurora has equipped its Customer Care and CRM teams with new technological tools that allow them to provide a better response to all their customers, and Microsoft has highlighted the project in question and considers it a success story. 

In May 2021 Cinzia Pavan decided to try Repigment12 and in just 35 days of treatment she saw how her skin began to regain its colour and she, her smile.

After 4 years of work alongside Dr. Matteo Bordignon, an Italian dermatologist specialising in the study of vitiligo, Bella Aurora, with more than 130 years of experience in the study of melanocytes, presents Repigment, its first effective treatment for white spots. 

From 29 September to 2 October, the 30th edition of the European Academy of Dermatology and Venereology (EADV) Congress was held virtually and Bella Aurora, specialist in the study of melanocyte behaviour, presented their latest launch to the international scientific community in a symposium: Repigment12